Mitochondrial Dysfunction in Alzheimer’s Disease and Mitochondria-Targeted Therapeutics
Cells · 28.05.2026 · 15 (11) · 990
DOI: 10.3390/cells15110990 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cells, online erschienen am 28.05.2026. Verfasst von Jasbir Bisht und 3 weiteren Autor:innen. Beteiligte Einrichtung: Obesity and Metabolic Health Laboratory, Department of Nutritional Sciences, Texas Tech University, Lubbock, TX 79409, USA. Hauptthemen laut MEDLINE: Alzheimer Disease, Mitochondria. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 166 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIH HHS, National Institutes of Health.
Themen: Demenz
Abstract (Originalsprache)
Alzheimer’s disease (AD) is the most prevalent form of dementia and is characterized by progressive cognitive decline due to the loss of neurons. The accumulation of extracellular senile plaques (Aβ) and intracellular tau neurofibrillary tangles (NFTs) is a key pathological feature of AD. Mitochondrial dysfunction is implicated in all key AD pathologies, whether as a cause or a consequence of disease progression. Growing evidence indicates that mitochondrial impairment plays a central role in AD pathogenesis by disrupting cellular homeostasis, promoting oxidative stress, and contributing to progressive neuronal death. Therefore, targeting mitochondria may offer promising insights into the development of disease-modifying therapies. In this review, we summarize current evidence on the role of mitochondrial dysfunction in the pathophysiology of AD and on its therapeutic potential.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Obesity and Metabolic Health Laboratory, Department of Nutritional Sciences, Texas Tech University, Lubbock, TX 79409, USA.
- Neurobiology of Nutrition Laboratory, Department of Nutritional Sciences, Texas Tech University, Lubbock, TX 79409, USA.
ORCID-Profile: Jasbir Bisht, Andrew C Shin, Vijay Hegde
Förderung
- NIH HHS
- National Institutes of Health
Zitieren
APA
Bisht, J., Rawat, P., Shin, A. C., & Hegde, V. (2026). Mitochondrial Dysfunction in Alzheimer’s Disease and Mitochondria-Targeted Therapeutics. Cells, 15(11), 990. https://doi.org/10.3390/cells15110990
Vancouver
Bisht J, Rawat P, Shin AC, Hegde V. Mitochondrial Dysfunction in Alzheimer’s Disease and Mitochondria-Targeted Therapeutics. Cells. 2026;15(11):990. doi:10.3390/cells15110990
BibTeX
@article{Bisht2026,
author = {Bisht, Jasbir and Rawat, Priyanka and Shin, Andrew C and Hegde, Vijay},
title = {Mitochondrial Dysfunction in Alzheimer’s Disease and Mitochondria-Targeted Therapeutics},
journal = {Cells},
year = {2026},
volume = {15},
number = {11},
pages = {990},
doi = {10.3390/cells15110990}
}
EUVIMED